AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Clinical trial NCT05247684 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05247684
Sponsor: Akeso
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Non-small Cell Lung Cancer

Start date: 2022-02-20
Primary completion: 2025-08-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.